Prospective clinical studies are still awaited
It is a synthetic growth-hormone secretagogue that has been studied preclinically and in early clinical research, but it is not an approved drug product
Do not open the refrigerator door to check on the medication, as this lets warm air in and reduces the cold reserve
Myth: If You Stop Your GLP-1 Medicine, You Will Gain All the Weight Back There is a risk of regaining weight after stopping GLP-1 receptor agonists, especially if underlying lifestyle changes, such as diet and exercise, are not maintained
Retatrutide is associated in research discussions with GLP-1, GIP, and glucagon receptor pathways
Ahead, we break down how injectable and oral GLP-1s compare, whats currently available and whats next in this fast-moving category